{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:21:26Z","timestamp":1780395686950,"version":"3.54.1"},"reference-count":38,"publisher":"SAGE Publications","issue":"s1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2024,8,20]]},"abstract":"<jats:p>Background: The interrelationship of parkinsonism, Parkinson\u2019s disease (PD) and other Alzheimer\u2019s disease (AD) and Alzheimer\u2019s disease and related dementias (ADRD) pathologies is unclear. Objective: We examined the progression of parkinsonian signs in adults with and without parkinsonism, and their underlying brain pathologies. Methods: Annual parkinsonian signs were based on a modified Unified Parkinson\u2019s Disease Rating Scale. We used linear mixed effects models to compare the progression of parkinsonian signs in 3 groups categorized based on all available clinical evaluations: Group1 (never parkinsonism or clinical PD), Group2 (ever parkinsonism, but never clinical PD), Group3 (ever clinical PD). In decedents, we examined the progression of parkinsonian signs with PD and eight other AD\/ADRD pathologies. Results: During average follow-up of 8 years, parkinsonian signs on average increased by 7.3% SD\/year (N\u200a=\u200a3,807). The progression of parkinsonian signs was slowest in Group1 (never parkinsonism or clinical PD), intermediate in Group2, and fastest in Group3. In decedents (n\u200a=\u200a1,717) pathologic PD and cerebrovascular (CVD) pathologies were associated with a faster rate of progressive parkinsonian signs (all p values &lt;0.05). However, pathologic PD was rare in adults without clinical PD (Group1, 5%; Group2, 7% versus Group3, 55%). Yet, 70% of adults in Group2 without pathologic PD showed one or more CVD pathologies. In Group2, adults with pathologic PD showed faster progression of parkinsonian signs compared with those without evidence of pathologic PD and their rate of progression was indistinguishable from adults with clinical PD. Conclusions: Parkinsonism in old age is more commonly related to cerebrovascular pathologies relative to pathologic PD and only a minority manifest prodromal PD.<\/jats:p>","DOI":"10.3233\/jad-240593","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T11:05:19Z","timestamp":1722942319000},"page":"S197-S209","source":"Crossref","is-referenced-by-count":5,"title":["Parkinson\u2019s Disease and Other Alzheimer\u2019s Disease and Related Dementia Pathologies and the Progression of Parkinsonism in Older Adults"],"prefix":"10.1177","volume":"100","author":[{"given":"Aron S.","family":"Buchman","sequence":"first","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, IL, USA"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, IL, USA"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Oveisgharan","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, IL, USA"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Zammit","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, IL, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Wang","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, IL, USA"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Shulman","sequence":"additional","affiliation":[{"name":"Department of Neurology and Center for Alzheimer\u2019s and Neurodegenerative Diseases, Baylor College of Medicine and Jan and Dan Duncan Neurological Research Institute, Texas Children\u2019s Hospital, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"VanderHorst","sequence":"additional","affiliation":[{"name":"Department of Neurology, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukrit","family":"Nag","sequence":"additional","affiliation":[{"name":"Department of Pathology (Neuropathology), Rush University Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, IL, USA"},{"name":"Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-240593_ref1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jalz.2014.04.514","article-title":"At the interface of sensory and motor dysfunctions and Alzheimer\u2019s disease","volume":"11","author":"Albers","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240593_ref2","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/mds.28777","article-title":"Mild parkinsonian signs: a systematic review of clinical, imaging, and pathological associations","volume":"36","author":"Buchanan","year":"2021","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-240593_ref3","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/mds.21433","article-title":"Mild parkinsonian signs: An overview of an emerging concept","volume":"22","author":"Louis","year":"2007","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-240593_ref4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes - key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-240593_ref5","first-page":"331","volume-title":"Progress in Brain Research","author":"Schaeffer","year":"2020"},{"key":"10.3233\/JAD-240593_ref6","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","article-title":"The Parkinson\u2019s progression markers initiative (PPMI) - establishing a PD biomarker cohort","volume":"5","author":"Marek","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-240593_ref7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-240593_ref8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1474-4422(06)70473-2","article-title":"Epidemiology of neurological diseases in elderly people: what did we learn from the Rotterdam Study?","volume":"5","author":"Hofman","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-240593_ref9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/gerona\/glaa176","article-title":"Person-specific contributions of brain pathologies to progressive parkinsonism in older adults","volume":"76","author":"Buchman","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-240593_ref10","doi-asserted-by":"crossref","first-page":"e1821","DOI":"10.1212\/WNL.0000000000007315","article-title":"Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies","volume":"92","author":"Buchman","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-240593_ref11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/gerona\/glv153","article-title":"Parkinsonism in older adults and its association with adverse health outcomes and neuropathology","volume":"71","author":"Buchman","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-240593_ref12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1212\/WNL.0000000000003059","article-title":"Incident parkinsonism in older adults without Parkinson disease","volume":"87","author":"Buchman","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-240593_ref13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.22588","article-title":"Nigral pathology and parkinsonian signs in elders without Parkinson disease","volume":"71","author":"Buchman","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-240593_ref14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2174\/156720512801322627","article-title":"The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia","volume":"9","author":"Barnes","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-240593_ref15","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.3233\/JAD-179939","article-title":"Religious Orders Study and Rush Memory and Aging Project","volume":"64","author":"Bennett","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240593_ref16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-240593_ref17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"H\u00f6glinger","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-240593_ref18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JPD-225111","article-title":"Proposal for a biologic staging system of Parkinson\u2019s disease","volume":"13","author":"Chahine","year":"2023","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JAD-240593_ref19","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/WNL.49.6.1580","article-title":"Metric properties of nurses\u2019 ratings of parkinsonian signs with a modified Unified Parkinson\u2019s Disease Rating Scale","volume":"49","author":"Bennett","year":"1997","journal-title":"Neurology"},{"key":"10.3233\/JAD-240593_ref20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson\u2019s disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.3233\/JAD-240593_ref21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson\u2019s syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.3233\/JAD-240593_ref22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00401-020-02212-z","article-title":"Brain pathologies are associated with both the rate and variability of declining motor function in older adults","volume":"140","author":"Buchman","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240593_ref23","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1002\/alz.13347","article-title":"Correlated decline of cognitive and motor phenotypes and ADRD pathologies in old age","volume":"19","author":"Buchman","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240593_ref24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.25123","article-title":"Person-specific contribution of neuropathologies to cognitive loss in old age","volume":"83","author":"Boyle","year":"2018","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-240593_ref25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to revised criteria for the diagnosis of Alzheimer\u2019s disease: National Institute on Aging and the Alzheimer\u2019s Association workgroup","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240593_ref26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.WNL.0000152982.47274.9E","article-title":"Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions","volume":"64","author":"Bennett","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-240593_ref27","first-page":"220","article-title":"The cell biology of Parkinson\u2019s disease","author":"Panicker","year":"2021","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-240593_ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat Med"},{"key":"10.3233\/JAD-240593_ref29","doi-asserted-by":"crossref","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell biology and pathophysiology of \u03b1-synuclein","volume":"8","author":"Burr\u00e9","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-240593_ref30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.06.025","article-title":"Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson\u2019s disease","volume":"56","author":"O\u2019Keeffe","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-240593_ref31","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.3233\/JAD-240593_ref32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ana.25179","article-title":"Do subjects with minimal motor features have prodromal Parkinson disease?","volume":"83","author":"Chu","year":"2018","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-240593_ref33","doi-asserted-by":"crossref","first-page":"e1976","DOI":"10.1212\/WNL.0000000000200182","article-title":"Association of statins with cerebral atherosclerosis and incident parkinsonism in older adults","volume":"98","author":"Oveisgharan","year":"2022","journal-title":"Neurology"},{"key":"10.3233\/JAD-240593_ref34","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1001\/jamaneurol.2021.3996","article-title":"Association of white matter hyperintensities with pathology and progression of parkinsonism in aging","volume":"78","author":"Oveisgharan","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-240593_ref35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00401-022-02527-z","article-title":"Brain and spinal cord arteriolosclerosis and its associations with cerebrovascular disease risk factors in community-dwelling older adults","volume":"145","author":"Oveisgharan","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240593_ref36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-230223","article-title":"Alzheimer\u2019s disease pathology outside of the cerebrum is related to a higher odds of dementia","volume":"96","author":"Buchman","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240593_ref37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/bpa.12560","article-title":"Spinal Lewy body pathology in older adults without an antemortem diagnosis of Parkinson\u2019s disease","volume":"28","author":"Buchman","year":"2018","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-240593_ref38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/gerona\/glac105","article-title":"Proteome-wide discovery ofcortical proteins that may provide motor resilience to offset the negative effects of pathologies in older adults","volume":"78","author":"Buchman","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-240593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:58:45Z","timestamp":1777370325000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-240593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":38,"journal-issue":{"issue":"s1"},"URL":"https:\/\/doi.org\/10.3233\/jad-240593","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]}}}